Clinical Trials Browser

Phase 2 × Advanced Biliary Tract Carcinoma × 90 days × Clear all

NCT05451290 2026-02-12

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

Phase 2 Active not recruiting

Gastrointestinal

Advanced Biliary Tract Carcinoma

NCT07036380 2026-01-09

TACTIC

Phase 2 Recruiting

Gastrointestinal

Advanced Biliary Tract Carcinoma